Tome Biosciences Launches with $213M in Funding, Targets ‘New Era’ of Genomic Medicines

Biotech startup Tome Biosciences emerged from stealth on Tuesday armed with with $213 million in funding from prominent investors and technology licensed from from the Massachusetts Institute of Technology.